{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:12:07Z","timestamp":1784099527550,"version":"3.55.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>The pathogenetic definition of a partial hydatidiform mole (PHM) is a diandric triploid gestation, thereby requiring short tandem repeat (STR) genotype testing for definitive diagnosis in formalin-fixed products of conception (POC) specimens. However, recent literature shows there is limited access to this test, even in high-income countries. Therefore, we hypothesized that in the United States, access to this test would be enriched in academic centers and commercial reference laboratories. We surveyed the Association for Molecular Pathology membership and directly queried selected commercial laboratories in the United States. The survey identified 13 laboratories (11 in academic centers, 2 in nonacademic centers, 0 commercial laboratories) that offered STR genotype testing for molar pregnancy diagnosis in formalin-fixed POC specimens. Four of the 13 laboratories did not accept specimens from pathologists outside of their health care system. Among the 9 who did, 8 first required that the specimen undergo formal diagnostic consultation in their surgical pathology department. Insufficient demand was the leading rationale reported by survey respondents from laboratories that did not offer this test at all. Separately, direct queries with client service representatives showed that only 1 of 16 selected commercial reference laboratories in the United States offered this test. Given the limited access to STR genotype testing, we propose a new reporting nomenclature system that reflects the level of diagnostic certainty for PHM, depending on whether the diagnosis is based on genotype analysis, ploidy analysis, or morphology alone. Further efforts are needed to educate pathologists who do have access to genotype analysis to select that test format rather than ploidy analysis to evaluate the concern for PHM.<\/jats:p>","DOI":"10.1097\/pas.0000000000002558","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:00:17Z","timestamp":1777582817000},"page":"917-923","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Limited Availability of Short Tandem Repeat Genotype Testing in the United States for Diagnosis of Partial Hydatidiform Mole"],"prefix":"10.1097","volume":"50","author":[{"given":"Laura","family":"Warren","sequence":"first","affiliation":[{"name":"Pathology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Tafe","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Laboratory for Clinical Genomics and Advanced Technology, Dartmouth Hitchcock Medical Center and Dartmouth Cancer Center, Lebanon, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Patrick","family":"Devine","sequence":"additional","affiliation":[{"name":"Pathology Department, Clinical Cancer Genomics Laboratory, University of California San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Rabban","sequence":"additional","affiliation":[{"name":"Pathology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"R1-20260715","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41379-021-00831-9","article-title":"Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine","volume":"34","author":"Buza","year":"2021","journal-title":"Mod Pathol"},{"key":"R2-20260715","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0046-8177(93)90061-K","article-title":"Diagnostic considerations in molar gestations","volume":"24","author":"Conran","year":"1993","journal-title":"Hum Pathol"},{"key":"R3-20260715","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/01.pas.0000157996.23059.c1","article-title":"Interobserver and intraobserver variability in the diagnosis of hydatidiform mole","volume":"29","author":"Fukunaga","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R4-20260715","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/PAS.0b013e31823b13fe","article-title":"Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis","volume":"36","author":"Vang","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R5-20260715","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/PGP.0b013e3182626011","article-title":"Partial hydatidiform mole: histologic parameters in correlation with DNA genotyping","volume":"32","author":"Buza","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"R6-20260715","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/his.15247","article-title":"Diandric triploid partial mole versus digynic nonmolar triploidy: is morphological assessment sufficient for the diagnostic distinction?","volume":"85","author":"Nagy","year":"2024","journal-title":"Histopathology"},{"key":"R7-20260715","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00004347-200110000-00001","article-title":"Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis","volume":"20","author":"Genest","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"R8-20260715","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1086\/302951","article-title":"Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole","volume":"66","author":"Zaragoza","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R9-20260715","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00428-023-03658-8","article-title":"Practical guidelines of the EOTTD for pathological and genetic diagnosis of hydatidiform moles","volume":"484","author":"Bartosch","year":"2024","journal-title":"Virchows Arch"},{"key":"R10-20260715","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/PAS.0000000000001466","article-title":"Prevalence of partial hydatidiform mole in products of conception from gestations with fetal triploidy merits reflex genotype testing independent of the morphologic appearance of the chorionic villi","volume":"44","author":"Han","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R11-20260715","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0046-8177(98)90067-3","article-title":"Prevalence of the partial molar phenotype in triploidy of maternal and paternal origin","volume":"29","author":"Redline","year":"1998","journal-title":"Hum Pathol"},{"key":"R13-20260715","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/modpathol.2013.143","article-title":"Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping","volume":"27","author":"Banet","year":"2014","journal-title":"Mod Pathol"},{"key":"R14-20260715","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/PAS.0b013e3181520034","article-title":"Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis","volume":"32","author":"Bifulco","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R15-20260715","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/jclinpath-2014-202517","article-title":"Clinical utility of selective molecular genotyping for diagnosis of partial hydatidiform mole; a retrospective study from a regional trophoblastic disease unit","volume":"67","author":"Fisher","year":"2014","journal-title":"J Clin Pathol"},{"key":"R16-20260715","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5858\/arpa.2012-0047-OA","article-title":"Diagnostic utility of microsatellite genotyping for molar pregnancy testing","volume":"137","author":"Furtado","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R17-20260715","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/AOG.0b013e3181d489ec","article-title":"Precise DNA genotyping diagnosis of hydatidiform mole","volume":"115","author":"Lipata","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R18-20260715","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/PAS.0b013e318191f309","article-title":"Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach","volume":"33","author":"McConnell","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R19-20260715","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2353\/jmoldx.2009.090039","article-title":"Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay","volume":"11","author":"Murphy","year":"2009","journal-title":"J Mol Diagn"},{"key":"R20-20260715","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41379-020-00691-9","article-title":"Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases","volume":"34","author":"Xing","year":"2021","journal-title":"Mod Pathol"},{"key":"R21-20260715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14737159.2025.2453506","article-title":"Gestational trophoblastic disease: STR genotyping for precision diagnosis","volume":"25","author":"Rozenova","year":"2025","journal-title":"Expert Rev Mol Diagn"},{"key":"R22-20260715","doi-asserted-by":"crossref","first-page":"100798","DOI":"10.1016\/j.modpat.2025.100798","article-title":"International feasibility of applying diagnostic essential criteria of the fifth edition World Health Organization classification of female genital tumors: evidence for a global gap in health care equity","volume":"38","author":"Rabban","year":"2025","journal-title":"Mod Pathol"},{"issue":"suppl 1(Iss 1 suppl 1","key":"R23-20260715","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/PGP.0000000000000515","article-title":"Current practices in the processing, diagnosis, and reporting of endometrial carcinoma: results of a web-based survey by the International Society of Gynecological Pathologists (ISGyP)","volume":"38","author":"Parkash","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"suppl 1(Iss 2 suppl 1","key":"R24-20260715","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/PGP.0000000000000744","article-title":"Survey results on pathologic aspects of endocervical adenocarcinoma by the International Society of Gynecological Pathologists","volume":"40","author":"McCluggage","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R25-20260715","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jcp-2023-209265","article-title":"Novel scoring system provides high separation of diploidy and triploidy to aid partial hydatidiform mole diagnosis: an adaption of HER2 D-DISH for ploidy analysis","volume":"78","author":"Joyce","year":"2025","journal-title":"J Clin Pathol"},{"key":"R26-20260715","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jcp-2023-209269","article-title":"Morphology combined with HER2 D-DISH ploidy analysis to diagnose partial hydatidiform mole: an evaluation audit using molecular genotyping","volume":"78","author":"Joyce","year":"2025","journal-title":"J Clin Pathol"},{"key":"R27-20260715","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2021.10.003","article-title":"Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: a Society of Gynecologic Oncology evidenced-based review and recommendation","volume":"163","author":"Horowitz","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"1-2","key":"R29-20260715","first-page":"47","article-title":"Psychologic impact of follow-up after low-risk gestational trophoblastic disease","volume":"56","author":"Lok","year":"2011","journal-title":"J Reprod Med"},{"key":"R30-20260715","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/1471-0528.16849","article-title":"The psychological impact of gestational trophoblastic disease: a prospective observational multicentre cohort study","volume":"129","author":"Blok","year":"2022","journal-title":"BJOG"},{"key":"R31-20260715","doi-asserted-by":"crossref","first-page":"e0128354","DOI":"10.1371\/journal.pone.0128354","article-title":"An investigative study into psychological and fertility sequelae of gestational trophoblastic disease: the impact on patients\u2019 perceived fertility, anxiety and depression","volume":"10","author":"Di Mattei","year":"2015","journal-title":"PLoS One"},{"key":"R32-20260715","first-page":"e13404","article-title":"Psychological factors influencing emotional reactions to gestational trophoblastic disease: the role of coping mechanisms and illness perception","volume":"30","author":"Di Mattei","year":"2021","journal-title":"Eur J Cancer Care (Engl)"},{"key":"R33-20260715","doi-asserted-by":"crossref","first-page":"2210747","DOI":"10.1080\/0167482X.2023.2210747","article-title":"Symptoms of anxiety and depression in women with gestational trophoblastic disease compared to women who had a miscarriage: a cross-sectional study","volume":"44","author":"Tenorio","year":"2023","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"R34-20260715","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1521-6934(03)00093-2","article-title":"Psychosocial and reproductive outcomes of gestational trophoblastic diseases","volume":"17","author":"Garner","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R35-20260715","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2022.03.039","article-title":"Experience of women on the Irish National Gestational Trophoblastic Disease Registry","volume":"272","author":"Joyce","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R36-20260715","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/IGC.0b013e3182259c04","article-title":"Long-term psychological morbidity, sexual functioning, and relationship outcomes in women with gestational trophoblastic disease","volume":"21","author":"Stafford","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R37-20260715","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-0042-1742681","article-title":"Emotional and clinical aspects observed in women with gestational trophoblastic disease: a multidisciplinary action","volume":"44","author":"Franca","year":"2022","journal-title":"Rev Bras Ginecol Obstet"},{"key":"R38-20260715","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2005.01.015","article-title":"The impact of molar pregnancy on psychological symptomatology, sexual function, and quality of life","volume":"97","author":"Petersen","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R39-20260715","doi-asserted-by":"crossref","first-page":"e001017","DOI":"10.1136\/bmjmed-2024-001017","article-title":"Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population study","volume":"4","author":"Swift","year":"2025","journal-title":"BMJ Med"},{"key":"R40-20260715","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2017.12.008","article-title":"What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients","volume":"148","author":"Coyle","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R41-20260715","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bpobgyn.2020.10.007","article-title":"Psychological aspects and fertility issues of GTD","volume":"74","author":"Di Mattei","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R42-20260715","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12958-022-00898-2","article-title":"Association between gestational trophoblastic disease (GTD) history and clinical outcomes in in vitro fertilization\/intracytoplasmic sperm injection (IVF\/ICSI) cycles","volume":"20","author":"Cai","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"R43-20260715","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejogrb.2021.01.051","article-title":"Obstetrics outcomes after complete and partial molar pregnancy: review of the literature and meta-analysis","volume":"259","author":"Capozzi","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R44-20260715","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/jcp-2023-209270","article-title":"Appraisal of hydatidiform mole incidence and registration rates in Ireland following the establishment of a National Gestational Trophoblastic Disease Registry","volume":"78","author":"Joyce","year":"2024","journal-title":"J Clin Pathol"},{"key":"R47-20260715","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000003566","article-title":"Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization following molar pregnancy: a systematic review and meta-analysis","volume":"135","author":"Albright","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R48-20260715","first-page":"1","article-title":"Births: final data for 2023","volume":"74","author":"Osterman","year":"2025","journal-title":"Natl Vital Stat Rep"},{"key":"R49-20260715","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/ijgc-2023-004526","article-title":"Gestational trophoblastic neoplasia: does centralization of care impact clinical management?","volume":"33","author":"Mitric","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"R50-20260715","doi-asserted-by":"crossref","first-page":"w20406","DOI":"10.4414\/smw.2021.20406","article-title":"Gestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre","volume":"151","author":"Fehlmann","year":"2021","journal-title":"Swiss Med Wkly"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:00:16Z","timestamp":1784098816000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002558"}},"subtitle":["A Dilemma for Practicing Precision Medicine"],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002558","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"2025-11-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}